Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells.

Loke P, Allison JP.

Arthritis Res Ther. 2004;6(5):208-14. Epub 2004 Aug 5. Review.

2.

The B7 family revisited.

Greenwald RJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2005;23:515-48. Review.

PMID:
15771580
3.

The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Wiendl H, Neuhaus O, Mehling M, Wintterle S, Schreiner B, Mitsdoerffer M, Wienhold W, Weissert R, Wessels J, Hartung HP, Weller M, Tolosa E, Melms A.

J Neuroimmunol. 2003 Jul;140(1-2):177-87.

PMID:
12864987
4.
5.

The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.

Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.

Int Immunol. 2005 Jan;17(1):73-83. Epub 2004 Nov 29.

PMID:
15569772
6.
7.
8.

The right place at the right time: novel B7 family members regulate effector T cell responses.

Liang L, Sha WC.

Curr Opin Immunol. 2002 Jun;14(3):384-90. Review.

PMID:
11973139
9.
10.
12.

Time courses of B7 family molecules expressed on activated T-cells and their biological significance.

Sun ZW, Qiu YH, Shi YJ, Tao R, Chen J, Ge Y, Hu YM, Ma HB, Shi Q, Zhang XG.

Cell Immunol. 2005 Jul-Aug;236(1-2):146-53. Epub 2005 Sep 12.

PMID:
16165113
13.

Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL.

Prilliman KR, Lemmens EE, Palioungas G, Wolfe TG, Allison JP, Sharpe AH, Schoenberger SP.

J Immunol. 2002 Oct 15;169(8):4094-7. Erratum in: J Immunol 2002 Nov 15;169(10):6056.

14.

Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.

Subauste CS, de Waal Malefyt R, Fuh F.

J Immunol. 1998 Feb 15;160(4):1831-40.

15.

An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.

Loser K, Scherer A, Krummen MB, Varga G, Higuchi T, Schwarz T, Sharpe AH, Grabbe S, Bluestone JA, Beissert S.

J Immunol. 2005 May 1;174(9):5298-305.

16.

T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties.

Ferlazzo G, Semino C, Meta M, Procopio F, Morandi B, Melioli G.

Eur J Immunol. 2002 Nov;32(11):3092-101.

17.

Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response.

Greenwald RJ, Lu P, Halvorson MJ, Zhou X, Chen S, Madden KB, Perrin PJ, Morris SC, Finkelman FD, Peach R, Linsley PS, Urban JF Jr, Gause WC.

J Immunol. 1997 May 1;158(9):4088-96.

PMID:
9126967
18.

B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N.

J Immunol. 2004 Sep 15;173(6):3631-9.

19.
20.

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.

Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ.

J Exp Med. 1994 Aug 1;180(2):631-40.

Supplemental Content

Support Center